Want to see FCEL full AI Analyst Report?
Operating Expense Breakdown
Details spending on key areas like R&D and marketing, offering a view into cost management and investment priorities.R&D ramped sharply through 2022–2023 then was pared back through 2024–2025, signaling a shift from heavy development toward commercialization and cash preservation; administrative and selling costs stayed relatively steady, showing tighter overhead control. Restructuring charges appear only sporadically beginning late‑2024, consistent with discrete cost actions. Importantly, the recent quarter’s large Groton impairment inflated operating expense and masks underlying OpEx progress—management’s commentary that core expenses fell and that scaling will follow contracted backlog supports a disciplined spending stance as they push toward volume-driven profitability.
Date | Research and Development | Restructuring | Administrative and Selling |
|---|---|---|---|
Jun 30, 2026 | $8.51M | $0.00 | $13.65M |
Mar 31, 2026 | $7.71M | $0.00 | $14.71M |
Dec 31, 2025 | $6.96M | $0.00 | $13.47M |
Sep 30, 2025 | $5.46M | -$256.00K | $15.18M |
Jun 30, 2025 | $7.65M | $4.05M | $14.07M |
Mar 31, 2025 | $9.90M | $6.00K | $16.47M |
Dec 31, 2024 | $11.08M | $1.54M | $15.03M |
Sep 30, 2024 | $11.61M | $2.56M | $15.95M |
Jun 30, 2024 | $12.82M | $0.00 | $14.60M |
Mar 31, 2024 | $16.63M | $0.00 | $17.66M |